Search Results 31-40 of 249 for ⚖[이천 부동산 문의 :1666-0375 ] 하이닉스 경기도이천이천시 청약예정⚖

  1. Phase 3 Study of T-DXd and Rilvegostomig versus SoC in Advanced HER2-expressing Biliary Tract Cancer - Mayo Clinic

    The purpose of this study is to to evaluate the efficacy and safety of T-DXd with rilvegostomig or T-DXd monotherapy vs gemcitabine, cisplatin and durvalumab as ...

  2. Pazopanib in Treating Patients with Metastatic Non-Clear Cell Kidney Cancer - Mayo Clinic

    Pazopanib hydrochloride may also stop the growth of kidney cancer by blocking blood flow to the tumor. Participation eligibility. Participant eligibility ...

  3. Double Cord Versus Haploidentical (Blood and Marrow Transplant Clinical Trials Network #1101)

    About this study. Hematopoietic cell transplants (HCT) are one treatment option for people with leukemia or lymphoma. Family members, unrelated donors or ...

  4. A Multi-Center Study Evaluating KTE-X19 in Pediatric and Adolescent Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia - Mayo Clinic

    This is a single arm, open-label, multi-center, phase 1/2 study, to determine the safety and efficacy of KTE-X19, an autologous anti-CD19 chimeric antigen ...

  5. https://www.mayoclinic.org/arabic_patient_consumer_web.xml

  6. A Study of Nab-Paclitaxel as Maintenance Treatment After Cisplatin-Based Chemotherapy and Surgery for Patients with High-Risk Bladder Cancer - Mayo Clinic

    Maintenance therapy, such as paclitaxel albumin-stabilized nanoparticle formulation, can help keep cancer from coming back after it has disappeared following ...

  7. Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer - Mayo Clinic

    Cobimetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving atezolizumab with cobimetinib may work better at ...

  8. Expediting Patient Identification of LGI1-IgG Autoimmune Encephalitis for Enrollment into Phase 2 Study - Mayo Clinic

    The purpose of this study is to expedite patient identification of LGI1-IgG autoimmune encephalitis patients for enrollment in the UCB sponsored phase 2 study ...

  9. A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Fruquintinib in Patients with Solid Tumors - Mayo Clinic

    The study is an open-label, dose escalation clinical trial to evaluate the safety, tolerability, and PK of fruquintinib in patients with advanced solid tumors.

  10. A Study to Learn More About Using Different Markers to Assess Kidney Function in Patients Before and After Methotrexate Therapy - Mayo Clinic

    About this study. The purpose of this study is to investigate the role that cystatin C and other novel renal biomarkers can have on improving the dosing and ...